Extract

Vibegron is a selective β3-adrenergic agonist.

Class: 86:12.08.12 • Selective beta-3 Adrenergic Agonists (AHFS primary) Brands: Gemtesa®

Uses

Vibegron has the following uses:

...

Dosage and Administration

General.

Vibegron is available in the following dosage form(s) and strength(s): Tablets: 75 mg.

Dosage.

It is essential that the manufacturer’s labeling be consulted for more detailed information on dosage and administration of this drug. Dosage summary:

Adults.

Dosage and Administration.

...

Cautions

Contraindications.

Do not use if prior hypersensitivity reaction to vibegron or any components of the product.

Warnings/Precautions.

Urinary Retention.

Urinary retention has been reported in patients taking vibegron. The risk of urinary retention may be increased in patients with bladder outlet obstruction and also in patients taking muscarinic antagonist medications for the treatment of OAB. Monitor patients for signs and symptoms of urinary retention, particularly in patients with bladder outlet obstruction and patients taking muscarinic antagonist medications for the treatment of OAB. Discontinue vibegron in patients who develop urinary retention.

You do not currently have access to this article.

Comments

0 Comments
Submit a comment
You have entered an invalid code
Thank you for submitting a comment on this article. Your comment will be reviewed and published at the journal's discretion. Please check for further notifications by email.